Condition
Major Depression Moderate
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Not Yet Recruiting1
Recruiting1
Enrolling By Invitation1
Terminated1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07503002Phase 1Not Yet RecruitingPrimary
Shortened LSD Intervention for Major Depressive Disorder
NCT07146269Not ApplicableEnrolling By InvitationPrimary
Virtual Reality-Augmented At-Home tDCS for Major Depression
NCT07140575Not ApplicableRecruitingPrimary
rTMS for Youth Inpatients With Depression
NCT03254342Terminated
MRS and Medication Response: A Pilot Study
Showing all 4 trials